A New Trial for CMT – When Science Moves Quickly

By Keith Fargo, Ph.D., Chief Scientific Officer, CMT Research Foundation   The pace of science can seem excruciatingly slow. It can take many years, or even decades, for new ideas to result in clinical trials. Every so often, though, the stars align and a new...

Teams at Cyprus Institute of Neurology & Genetics and Nationwide Children’s Hospital Complete CMT Research Foundation-Funded Project, Resulting Therapeutic Now Moving into Pharmaceutical Development

Update, May 17, 2022: This work is now published in The Journal of Clinical Investigation.  By Keith Fargo, Ph.D., Chief Scientific Officer, CMT Research Foundation The CMT Research Foundation is pleased to announce that Dr. Kleopas Kleopa, a renowned neuromuscular...

CMT Research Foundation partners with Biotechnology Company AcuraStem and CMT Researcher Alessandra Bolino to test new drug in CMT4B1

The CMT Research Foundation is proud to announce our latest project, a partnership between AcuraStem, a patient-based drug discovery platform company, and Dr. Alessandra Bolino, a renowned expert in CMT and the head of the Human Inherited Neuropathies Unit at the...